Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Genet Med. 2022 Oct;24(10):2208. doi: 10.1016/j.gim.2022.08.005.
No abstract available

Publication types

  • Published Erratum